YOLFTbeta
EZZ Life Science Holdings Ltd

EZZ Life Science Holdings Ltd

EZZ · AU · Healthcare / Biotechnology

0.295AUD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.295
Open0.295
Day Range0.295 – 0.295
52-Week Range0.355 – 3.35
Volume1.69K
Market Cap17.41M
P/E (TTM)6.17
Forward P/E0.00
EPS0.06
Dividend Yield10.81%
Beta0.96
50-Day Avg0.4676
200-Day Avg0.8664

About

EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, South-East Asia, and internationally. The company operates through two segments, Brought in Lines and Company Owned Products. It is involved in the wholesale distribution of the EAORON branded skin care products to retailers; and direct-to-consumer distribution through e-commerce store. The company provides health and wellness products under the EZZ brand. It also offers its products online. The company was incorporated in 2015 and is based in Lidcombe, Australia.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Qizhou Qin
  • Employees0
  • HeadquartersShop 1, 55-59 Parramatta Road, Lidcombe, NSW, Australia, 2141, Australia
  • Websitehttps://ezzlife.com.au

Leadership

  • Mr. Qizhou QinCo-Founder, COO, CEO & Executive Director
  • Mr. Anthony GuarnaChief Financial Officer
  • Dr. Glenn CrossChief Strategy Officer · b. 1951
  • Ms. Christina ChenExecutive Director
  • Mr. Jay StephensonCompany Secretary
  • Mr. James HudsonDirector of Corporate Affairs

Financials

Income Statement

Currency: AUD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue11.19M17.32M22.29M15.02M37.14M66.44M66.87M46.28M
Growth (%)-+54.77%+28.71%-32.60%+147.26%+78.88%+0.65%-30.79%
Cost of Revenue6.83M13.75M9.83M7.51M9.94M15.50M17.15M20.51M
Gross Profit4.36M3.56M12.46M7.51M27.20M50.95M49.72M25.77M
Gross Margin38.98%20.57%55.90%49.98%73.24%76.67%74.35%55.68%
Operating Expense3.18M2.08M9.89M5.87M22.59M41.23M39.79M32.38M
Operating Income1.18M1.48M2.57M1.64M4.62M9.72M9.93M-6.61M
Operating Margin10.52%8.55%11.54%10.93%12.43%14.62%14.85%-14.28%
EBITDA1.18M2.30M2.87M1.90M5.09M10.38M11.10M-6.12M
EBITDA Margin10.55%13.30%12.89%12.67%13.71%15.62%16.60%-13.22%
Net Income823.81K1.59M2.03M1.31M3.63M6.96M6.73M-5.32M
Net Income Margin7.36%9.16%9.11%8.74%9.77%10.48%10.06%-11.50%
Interest Expense05.91K10.75K4.44K10.41K24.75K27.84K17.31K
Interest Expense % of Total Revenue0.00%0.03%0.05%0.03%0.03%0.04%0.04%0.04%

Balance Sheet

Currency: AUD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1002.91M11.63M12.04M14.27M17.64M25.55M33.96M27.64M
Total Liabilities02.09M3.78M1.93M2.88M3.06M4.23M5.87M3.15M
Total Equity100823.91K7.85M10.11M11.39M14.58M21.32M28.09M24.49M
Cash100413.89K8.41M8.85M10.46M13.83M19.02M20.85M9.72M
Total Debt--32.00K79.01K104.57K478.60K123.86K304.49K478.59K
Net Debt--413.89K-8.38M-8.77M-10.36M-13.35M-18.90M-20.54M-9.25M

Cash Flow

Currency: AUD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow416.33K2.97M253.53K1.90M4.01M6.14M4.35M-8.76M
Investing Cash Flow-2.54K-91.20K-16.12K-13.18K-101.78K-441.17K-546.93K-652.32K
Financing Cash Flow-122.25K-122.25K5.44M-277.36K-761.72K-582.45K-2.17M-1.26M
Capital Expenditure2.54K91.20K16.12K13.18K101.78K409.29K260.88K29.70K
Free Cash Flow413.79K2.88M237.42K-13.18K3.91M5.73M4.09M-8.79M
Dividends Paid173.17K173.17K107.27K173.17K600.39K1.08M1.82M902.94K
FCF to OCF99.39%96.93%93.64%-0.69%97.46%93.34%94.01%100.34%
Dividend Paid to FCF41.85%6.01%45.18%-1314.26%15.35%18.86%44.40%-10.27%

Earnings

Report DateMar 1, 2021Aug 31, 2021Feb 28, 2022Aug 31, 2022Feb 27, 2023Nov 27, 2024Feb 25, 2025Aug 29, 2025
EPS Estimate0.000.000.000.000.000.000.000.00
EPS Actual0.030.020.000.030.030.000.070.07
Surprise--------
Timing--------

Key Statistics & Ratios

Market Cap17.41M
Enterprise Value6.17M
Trailing P/E6.17
Forward P/E0.00
Price / Sales0.38
Price / Book0.70
EPS0.06
Book Value0.52
Revenue (TTM)46.28M
Gross Profit (TTM)31.27M
EBITDA-6.48M
Profit Margin-11.50%
Operating Margin-30.29%
Return on Equity-20.25%
Return on Assets-13.41%
Shares Outstanding47.04M
Shares Float13.37M
Beta0.96
Dividend Yield10.81%
Dividend Rate0.04
Payout Ratio65.25%

Dividends

20252×
0.02Nov 24, 20250.02May 16, 2025
20242×
0.02Nov 5, 20240.01May 16, 2024
20232×
0.01Oct 30, 20230.01May 22, 2023
20221×
0.00Nov 3, 2022
20211×
0.00Nov 9, 2021